Prime Medicine, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2021 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Prime Medicine, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2021 to Q3 2024.
- Prime Medicine, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$52.5M, a 3.57% decline year-over-year.
- Prime Medicine, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$219M, a 27.6% decline year-over-year.
- Prime Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$198M, a 62.6% decline from 2022.
- Prime Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$122M, a 26.3% increase from 2021.
- Prime Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$165M, a 4749% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)